Wuhan Frasergen Bioinformatics Co., Ltd.
PrivateLast Round
Series C
Feb 2, 2023
Total Funding Raised
$7.54M
Company Overview
Wuhan Frasergen Bioinformatics Co., Ltd. is a biotechnology company that provides bioinformatics and genomics research services, including sequencing, data analysis, and molecular marker development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Wuhan Frasergen Bioinformatics Co., Ltd. Comparables
Compare Wuhan Frasergen Bioinformatics Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Guangzhou Genedenovo Biotechnology Co., Ltd. | 87% | |
| Annoroad Gene Technology | 81% | |
| Novogene Co. Ltd. | 79% | |
Wuhan Frasergen Bioinformatics Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Feb 2, 2023 | ||||
| Series B Extension | Jan 25, 2018 | ||||
| Series B | Nov 12, 2017 | ||||
| Series A | Jun 1, 2017 |
Wuhan Frasergen Bioinformatics Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alwin Capital | Series B |
| 融和资本 | Series A |
| 合源资本管理有限公司 | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 2, 2023
Raised Series C round.
- Jan 25, 2018
Raised Series B Extension round with investment from 合源资本管理有限公司.
Wuhan Frasergen Bioinformatics Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Wuhan Frasergen Bioinformatics Co., Ltd.'s valuation, stock price, and market status.